Trial studying safety and effects for Alzheimers Disease Related Dementias
Official title Evaluating the Effectiveness of the Health App Recommendation Tool
ClinicalTrials.gov ID: NCT07216716
What this study is testing
- What it's testing
- This study is testing whether the Health App Recommendation Tool (HART) is easy to use and helpful for people with Alzheimer’s disease and their caregivers.
- Who it's for
- You may be able to join if you are a family caregiver of someone with Alzheimer’s disease or a related dementia.
- What's involved
- You will use the HART tool at home, look at the apps it suggests, and answer short surveys about how easy it is to use. You will do this twice, once before and once after a four‑week period.
- Time commitment
- The study lasts four weeks and requires two visits to complete surveys and use the tool.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Aged between 18 and 65
- Serving as an active caregiver for a loved one with Alzheimer's disease or a related dementia
- Have access to smart devices such as smartphones, tablets, or smartwatches
You likely can't join if
- Individuals with Alzheimer's disease or a related dementia, or with severe cognitive decline, will be excluded
- Participants who do not provide caregiving on a routine basis (e.g., part-time or secondary caregivers) will be excluded
- Participants who do not own or have access to any smart device will be excluded
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.